Dupixent\u00ae (dupilumab) Demonstrated Superiority Over Xolair\u00ae (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (

• click to rate

  Posted by Two Blokes Jun 15 - Filed in Stock - 2 views
  
  New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints